Press release
Global U.S. Respiratory Syncytial Virus Vaccines Market Analysis 2022 Forecasts to 2032
According to recent industry analysis on the U.S. respiratory syncytial virus vaccines market by Persistence Market Research, a leading market research company, the industry is projected to be valued at US$ 320.3 Mn in 2022, and is set to expand at a CAGR of 18.2% over the next ten years. Demand for RSV vaccines in the U.S. is expected to increase manifold due to a large numbers of ongoing clinical trials and a strong product pipeline displaying promising results.During the past 10 years, considerable progress has been made in RSV vaccine development. Key manufacturers of these vaccines are using monoclonal antibodies to cause passive immunization in infants. At present, there are around 17 new RSV vaccines under clinical development, which include live attenuated, vector-based, particle-based, and subunit vaccines.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/33045
Presently, key market players such as GSK, Janssen, Moderna, and Pfizer have global phase III trials underway for RSV vaccines, which reflects a great opportunity for industrial growth along with the launch of these products into the market in the future. Increasing funding from government bodies plays a vital role in driving demand for the market by supporting R&D activities in the country.
Thus, active participation of key players in clinical trials and financial help from the government will contribute in driving the respiratory syncytial virus vaccines market in the U.S. to reach a valuation of US$ 1.7 Bn by the end of 2032.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/33045
Key Takeaways from Market Study
By drug, Nirsevimab (MEDI8897) is projected to dominate the U.S. market with US$ 406.6 Mn valuation by 2032.
Based on distribution channel, institutional sales are expected to dominate the market with revenue worth US$ 754.3 Mn by 2032.
"Increasing number of products in clinical pipeline is anticipated to drive the U.S. market for respiratory syncytial virus vaccines," says a Persistence Market Research analyst.
Market Competition
Key manufacturers of respiratory syncytial virus (RSV) vaccines are focusing on inorganic growth by undergoing clinical trials on RSV vaccines for expansion of their market share and presence, along with strengthening their capabilities with broader offerings to meet growing market demand.
This approach helps in the development of cost-effective vaccines with higher efficacy and performance, which is expected to drive market growth during the forecast period (2022 to 2032).
In February 2022, GlaxoSmithKline plc announced a voluntary pause in the trial enrolment and vaccination evaluating a potential RSV maternal vaccine candidate in pregnant women.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the U.S. respiratory syncytial virus vaccines market in its latest study, presenting historical demand assessment of 2017 - 2021 and projections for 2022 - 2032.
The research study is based on the drug (Palivizumab, RSVpreF PF06928316, RSVPreF3 OA (GSK3844766A), mRNA-1345, mRNA-1345, Janssen RSV Vaccine, ResVax, Nirsevimab (MEDI8897), and MVA-BN RSV) and distribution channel (institutional sales, retail sales, and online sales), in the U.S.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/33045
Access PMR Exclusive Reports-
Crushed Red Pepper Market- https://www.persistencemarketresearch.com/market-research/crushed-red-pepper-market.asp
Dried Fruits Market- https://www.persistencemarketresearch.com/market-research/dried-fruits-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global U.S. Respiratory Syncytial Virus Vaccines Market Analysis 2022 Forecasts to 2032 here
News-ID: 2668443 • Views: …
More Releases from Persistence Market Research

Laboratory Electronic Balance Market Expected to Witness Impressive Growth at a …
The laboratory electronic balance market plays a crucial role in ensuring precise and accurate measurement of mass across a wide range of scientific, industrial, and academic applications. These instruments are extensively used in pharmaceutical research, biotechnology, chemical analysis, food testing, and material sciences. They offer superior sensitivity, user-friendly digital interfaces, and high repeatability, making them indispensable in laboratories where precision is critical.
Request a Sample: https://www.persistencemarketresearch.com/samples/3189
According to the latest study…

Biological Safety Testing Market to Register High CAGR of 11.3% Through 2032
The global biological safety testing market is poised for significant growth in the coming years, with market valuation expected to rise from USD 4.85 billion in 2025 to USD 10.26 billion by 2032, registering a robust compound annual growth rate (CAGR) of 11.3% during the forecast period. This growth trajectory is primarily fueled by the increasing demand for biopharmaceuticals, stringent regulatory requirements across the globe, and rapid advancements in biotechnology…

Beverage Refrigeration Equipment Market Innovations, Efficiency, and Emerging Tr …
The global beverage refrigeration equipment market is witnessing rapid growth as businesses and consumers increasingly demand efficient, reliable, and technologically advanced solutions for cooling beverages. Beverage refrigeration equipment, ranging from commercial coolers and display refrigerators to industrial-grade storage units, plays a pivotal role in maintaining product quality, freshness, and consumer satisfaction.
The global beverage refrigeration equipment market size is likely to be valued at US$2.2 Bn in 2025 and is…

U.S. CMO/CDMO Market Forecast Highlights Significant CAGR of 8.7% from 2025-2032
The U.S. Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) market is poised for robust expansion, driven by growing demand across pharmaceutical and biopharmaceutical sectors. Valued at approximately US$83.1 billion in 2025, the market is projected to reach US$149.4 billion by 2032, registering a compound annual growth rate (CAGR) of 8.7% during the forecast period. This growth trajectory reflects increased outsourcing of key drug development and manufacturing…
More Releases for RSV
The Rise In The Prevalence Of RSV Infection : Transformative Forces Shaping the …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Respiratory Syncytial Virus (RSV) Therapeutics Industry Market Size Be by 2025?
The market size for therapeutics treating the respiratory syncytial virus (RSV) has seen significant expansion in the past few years. It is expected to surge from $1.6 billion in 2024 to $2 billion in 2025,…
RSV Vaccine Market To Reach 731 million by 2040, Due To Increasing Awareness on …
According to our latest market report "RSV Vaccine Market, Till 2040 by Type of Vaccine, Route of Administration, Target Patient Population, Distribution Channel, Key Geographical Regions and Leading Players", the RSV Vaccine market size is projected to reach USD 731 million by 2040 from USD 1,149 million in current year, during the forecast period.
To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/rsv-vaccine-market/request-quote.html
In the dynamic landscape of preventive therapies for respiratory…
RSV Diagnostics Market to Signify Strong Growth by 2024-2031
The RSV (Respiratory Syncytial Virus) Diagnostics market is experiencing significant growth due to the increasing prevalence of RSV infections, advancements in diagnostic technologies, and the rising demand for accurate and rapid diagnostic solutions. RSV is a common respiratory virus that causes infections in the lungs and respiratory tract, particularly affecting infants, young children, and the elderly.
Market Overview
The global RSV Diagnostics market is projected to witness substantial growth over the coming…
Global RSV Diagnostic Products Market Size & Trends
According to a new market research report published by Global Market Estimates, the global RSV diagnostic products market is expected to grow at a CAGR of 11.4% from 2023 to 2028.
Ongoing advancements in diagnostic technologies, specifically PCR and rapid point-of-care testing, play a crucial role. These advancements offer heightened accuracy, faster results, and increased accessibility, enabling prompt and precise identification of RSV infections.
Browse 147 Market Data Tables and 115 Figures…
Respiratory Syncytial Virus (RSV) Therapeutics Market Size to Reach USD 9080.84 …
Respiratory Syncytial Virus (RSV) Therapeutics Market Scope & Overview
Respiratory Syncytial Virus (RSV) Therapeutics Market size was USD 1040.65 Million in 2022 and is expected to Reach USD 9080.84 Million by 2030 and grow at a CAGR of 31.1% over the forecast period of 2023-2030.
The Respiratory Syncytial Virus (RSV) Therapeutics market is a vibrant, fiercely competitive sector that is essential to digital marketing. The demand for effective has increased as companies…
Respiratory Syncytial Virus (RSV) Therapeutics Market - Conquering RSV: Advancin …
Newark, New Castle, USA: The "Respiratory Syncytial Virus (RSV) Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Respiratory Syncytial Virus (RSV) Therapeutics Market: https://www.growthplusreports.com/report/respiratory-syncytial-virus-rsv-therapeutics-market/8519
This latest report…